- Home
- ARBB vs BOLT Comparison
ARBB vs BOLT Comparison
Compare ARBB & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBB
- BOLT
- Stock Information
- Founded
- ARBB 1997
- BOLT 2015
- Country
- ARBB Singapore
- BOLT United States
- Employees
- ARBB N/A
- BOLT N/A
- Industry
- ARBB EDP Services
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- ARBB Technology
- BOLT Health Care
- Exchange
- ARBB Nasdaq
- BOLT Nasdaq
- Market Cap
- ARBB 18.0M
- BOLT 16.8M
- IPO Year
- ARBB 2023
- BOLT 2021
- Fundamental
- Price
- ARBB $0.69
- BOLT $0.36
- Analyst Decision
- ARBB
- BOLT Hold
- Analyst Count
- ARBB 0
- BOLT 5
- Target Price
- ARBB N/A
- BOLT $1.13
- AVG Volume (30 Days)
- ARBB 4.6M
- BOLT 105.6K
- Earning Date
- ARBB 05-16-2025
- BOLT 05-13-2025
- Dividend Yield
- ARBB N/A
- BOLT N/A
- EPS Growth
- ARBB N/A
- BOLT N/A
- EPS
- ARBB N/A
- BOLT N/A
- Revenue
- ARBB $24,425,491.00
- BOLT $7,690,000.00
- Revenue This Year
- ARBB N/A
- BOLT N/A
- Revenue Next Year
- ARBB N/A
- BOLT $77.48
- P/E Ratio
- ARBB N/A
- BOLT N/A
- Revenue Growth
- ARBB N/A
- BOLT N/A
- 52 Week Low
- ARBB $0.22
- BOLT $0.30
- 52 Week High
- ARBB $1.24
- BOLT $1.34
- Technical
- Relative Strength Index (RSI)
- ARBB 49.32
- BOLT 47.10
- Support Level
- ARBB $0.65
- BOLT $0.33
- Resistance Level
- ARBB $0.73
- BOLT $0.38
- Average True Range (ATR)
- ARBB 0.05
- BOLT 0.03
- MACD
- ARBB -0.00
- BOLT 0.00
- Stochastic Oscillator
- ARBB 27.38
- BOLT 32.47
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.